Icecure Medical
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.08
- Today's High:
- $1.1101
- Open Price:
- $1.08
- 52W Low:
- $0.75
- 52W High:
- $2.6
- Prev. Close:
- $1.11
- Volume:
- 48826
Company Statistics
- Market Cap.:
- $50.79 million
- Book Value:
- 0.404
- Revenue TTM:
- $3.22 million
- Operating Margin TTM:
- -499.1%
- Gross Profit TTM:
- $1.45 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -43.2%
- Return on Equity TTM:
- -83.97%
Company Profile
Icecure Medical had its IPO on 2021-08-26 under the ticker symbol ICCM.
The company operates in the Healthcare sector and Medical Devices industry. Icecure Medical has a staff strength of 65 employees.
Stock update
Shares of Icecure Medical opened at $1.08 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.08 - $1.11, and closed at $1.11.
This is a 0% increase from the previous day's closing price.
A total volume of 48,826 shares were traded at the close of the day’s session.
In the last one week, shares of Icecure Medical have increased by +0.91%.
Icecure Medical's Key Ratios
Icecure Medical has a market cap of $50.79 million, indicating a price to book ratio of 2.4098 and a price to sales ratio of 10.749.
In the last 12-months Icecure Medical’s revenue was $3.22 million with a gross profit of $1.45 million and an EBITDA of $-15769000. The EBITDA ratio measures Icecure Medical's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Icecure Medical’s operating margin was -499.1% while its return on assets stood at -43.2% with a return of equity of -83.97%.
In Q2, Icecure Medical’s quarterly earnings growth was a positive 0% while revenue growth was a positive 22.5%.
Icecure Medical’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.42 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Icecure Medical’s profitability.
Icecure Medical stock is trading at a EV to sales ratio of 6.8481 and a EV to EBITDA ratio of -1.5378. Its price to sales ratio in the trailing 12-months stood at 10.749.
Icecure Medical stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $22.69 million
- Total Liabilities
- $3.86 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $72000
- Dividend Payout Ratio
- 0%
Icecure Medical ended 2024 with $22.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $22.69 million while shareholder equity stood at $18.44 million.
Icecure Medical ended 2024 with $0 in deferred long-term liabilities, $3.86 million in other current liabilities, in common stock, $-83066000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.03 million and cash and short-term investments were $3.03 million. The company’s total short-term debt was $208,000 while long-term debt stood at $0.
Icecure Medical’s total current assets stands at $20.43 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $707000.00 compared to accounts payable of $652000.00 and inventory worth $2.75 million.
In 2024, Icecure Medical's operating cash flow was $0 while its capital expenditure stood at $72000.
Comparatively, Icecure Medical paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.11
- 52-Week High
- $2.6
- 52-Week Low
- $0.75
- Analyst Target Price
- $3.93
Icecure Medical stock is currently trading at $1.11 per share. It touched a 52-week high of $2.6 and a 52-week low of $2.6. Analysts tracking the stock have a 12-month average target price of $3.93.
Its 50-day moving average was $1.12 and 200-day moving average was $1.19 The short ratio stood at 0.2 indicating a short percent outstanding of 0%.
Around 4699.7% of the company’s stock are held by insiders while 79.9% are held by institutions.
Frequently Asked Questions About Icecure Medical
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.